Quote Nimacimab
Nimacimab (RYI-018) is a negative-allosteric modulating monoclonal antibody targeting CB1 receptor. Nimacimab can be used for research of metabolic diseases.
Read more
€0.00
(tax incl.)
Reference:
HY-P99755
Brand: